NEW YORK, March 1, 2017 /PRNewswire/ --
A research report by Markets and Markets indicates that the sample preparationmarket is forecasted to reach approximately USD 7.2 billion in sales by 2021, from about USD 5.5 billion in 2016, growing at CAGR of 5.5%. In the medical field sample preparations refers to
The research also indicates that a shift from the more traditional manual techniques, to automated sample preparation is a major factor contributing to the sample preparation market. Mass spectrometry (MS) is a highly selective analytic technique which provides significantly more accurate measurements and as a result, is now being used in an increasing number of clinical laboratories. MS ionizes chemical species and sorts the ions based on mass to charge ratio. It can be used in various fields, applied to pure samples and complex mixtures.
Pressure BioSciences, Inc. (OTCQB: PBIO) is the developer and seller of broadly enabling, pressure cycling technology ("PCT") - based sample preparation solutions to the worldwide life sciences industry. Earlier today the company announced that, "its Barocycler 2320EXTREME ("2320EXT") has been named the "Best New Instrument for Sample Preparation 2017" by Corporate America News ("Corp America") as part of the publication's 2017 North American Excellence Awards. With a subscription list of more than 135,000 business and professional service providers, Corp America is a leading magazine in the U.S business market. The magazine's annual North American Excellence Awards honor companies and individuals who tirelessly work to drive innovation and exhibit true passion for their work.
The award-winning, next generation Barocycler 2320EXT is the latest addition to PBI's Barocycler family. It is a compact, bench top instrument offering many advanced features and benefits. These and other additions have already positioned the Barocycler 2320EXT as an instrument of choice for life science key opinion leaders ("KOLs") worldwide, when preparing protein samples for analysis.
Dr. Nate Lawrence, Vice President of Marketing and Sales for PBI, said: "We are honored to have been selected for this prestigious award. It was just eight months ago when we launched this next-generation Barocycler instrument, the 2320EXT. Since then, the instrument has been purchased by key scientists in academic, government, biotech and pharma labs worldwide, including institutions involved in the Cancer Moonshot Initiative. We believe this award affirms the significant potential of the Barocycler 2320EXT."
ProCan, a cancer research initiative located in the Children's Medical Research Institute near Sydney Australia, and a Cancer Moonshot collaborator, purchased three Barocycler 2320EXTs in June 2016. At the time of their purchase, Professor Phil Robinson, co-head of ProCan, said: "Patient tumor samples can be pretty tiny and very heterogeneous, but the use of PCT in sample preparation allows researchers to analyze tissue samples as small as those provided by needle biopsies. So you can use incredibly small amounts of tissue, reliably digest them in a couple of hours, and get large amounts of information with the Barocycler 2320EXT."
Professor Ruedi Aebersold, a world-renowned protein chemist who recently upgraded to the Barocycler 2320EXT, emphasizes the importance of sample preparation in the article. Dr. Aebersold said: "Not only do we need to consider the method of analyzing the proteome, but we must also recognize that the method of sample preparation used to optimize protein extraction & digestion is equally as important."
Dr. Lawrence commented: "It is the support of KOLs like Professors Robinson and Aebersold that we believe helped convince the panel of judges that the Barocycler 2320EXT deserved to win the 2017 North American Excellence Award for Best New Sample Preparation Instrument."
PBI President and CEO Richard T. Schumacher was interviewed by the magazine upon selection of the award. In a four-page article, Mr. Schumacher provides an in-depth overview of PBI's patented PCT technology and its unique advantages, the Company's history of innovation and growth, its large market opportunity, additional features and benefits of the 2320EXT, the recent co-marketing agreement with global life sciences leader SCIEX, and his expectations that significant growth is on the horizon. To view the full article, visit http://www.corporateamericanews.com/2017-north-american-excellence-awards and turn to page 8.
Pressure BioSciences, previously announced an exclusive co-marketing agreement with SCIEX, a company focuses on science analytical technologies, and a wholly-owned subsidiary of Danaher Corporation (NYSE: DHR). Under the agreement, the companies will jointly promote Pressure BioSciences' PCT-based sample preparation systems and SCIEX's mass spectrometry equipment, with a focus on improved sample preparation. Danaher offers a comprehensive product range for each step in the pathology process, from sample preparation and staining to imaging and reporting. As the only company to own the full workflow from biopsy to diagnosis, Leica Biosystems is uniquely positioned to break down the barriers between each step. The company's goal is to make diagnosis within 24 hours of a biopsy possible. Danaher operates in five segments: Test & Measurement, Environmental, Life Sciences & Diagnostics, Dental, and Industrial Technologies.
Illumina Inc. (NASDAQ: ILMN) is a provider of sequencing- and array-based solutions for genetic analysis. The company's product, TruSeq® DNA PCR-Free Library Preparation Kits provide simple, all-inclusive library preparation for whole-genome sequencing applications. Researchers can sequence a wide variety of organisms, from small genomes such as bacteria to human whole-genomes. The kits offer shortened gel-free workflows that remove the need for PCR, the ability to sequence the most challenging regions and improved genome coverage to identify the greatest number of variants. By removing PCR, it creates a faster protocol and superior data quality.
PerkinElmer Inc. (NYSE: PKI) is a provider of products, services and solutions to the diagnostics, research, environmental and laboratory markets. The company provides with a portfolio of sample preparation supplies that ensures successful preparation, including consumables for microwave digestion systems, Sample Preparation Blocks (SPBs), and Solid Phase Extraction (SPE) for a broad range of applications. The company's Human Health segment concentrates on developing diagnostics, tools and applications to help detect diseases earlier. Within its Human Health segment, the Company serves the diagnostics and research markets.
Provider of application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow, Agilent Technologies Inc. (NYSE: A) offers sample preparation products that help achieve analytical goals. The company offers syringe filters with a complete membrane portfolio for all sample types. Other Captiva products include cartridges and plates for protein precipitation workflows. For more complex needs, Bond Elut solid phase extraction (SPE) products feature sorbents with phases for different analyte extraction and cleanup needs. QuEChERS kits include extraction salts and dispersive SPE tubes ideal for food applications.
Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
For further information: Media Contact: [email protected], +1-877-601-1879
Subscribe to our Free Newsletters!
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...
Spinal anesthesia and epidural anesthesia are types of regional anesthesia in which when a drug is ...View All